Robert W Finberg

Title: The Innovations of Robert W. Finberg

Introduction

Robert W. Finberg is a notable inventor based in Canton, MA (US), recognized for his significant contributions to the field of medical science. He holds a total of 5 patents, showcasing his innovative approach to addressing critical health issues.

Latest Patents

Among his latest patents, Finberg has developed a herpesvirus vaccine that comprises a mutated herpesvirus suspended in a pharmaceutically acceptable carrier. This innovative vaccine is designed to infect the cells of the mammal being vaccinated, while being incapable of completing a replicative cycle. It elicits a protective immune response and has potential applications in treating immunomodulatory or immunoregulatory diseases. Another significant patent involves the use of G protein binding agents for the prophylactic and therapeutic treatment of septic shock. This invention outlines methods for using these agents to treat subjects who are susceptible to septic shock, along with compositions that include an effective amount of a G protein binding agent, and optionally, an antibiotic.

Career Highlights

Throughout his career, Finberg has worked with esteemed organizations, including the Dana-Farber Cancer Institute Inc. His work has had a profound impact on the medical community, particularly in the areas of infectious diseases and immunology.

Collaborations

Finberg has collaborated with notable colleagues such as Evelyn A. Kurt-Jones and Keith R. Solomon, contributing to advancements in their respective fields.

Conclusion

Robert W. Finberg's innovative work and patents reflect his dedication to improving health outcomes through scientific research and development. His contributions continue to influence the medical field significantly.